Macter expands Cobolmin range with sublingual option

MG News | December 22, 2025 at 03:55 PM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

December 22, 2025 (MLN): Macter International Limited (PSX: MACTER) introduced Cobolmin SL, a sublingual formulation of Mecobalamin.

The company stated that Cobolmin SL offers rapid absorption and enhanced convenience for patients through sublingual administration, the company’s filing on PSX revealed today.

The product expands the existing Cobolmin range, which includes tablets and injections, and underscores Macter International’s focus on innovation in healthcare.

At the time of writing, MACTER shares were trading at Rs 337.59, up 2.51 points, or 0.75%.

Copyright Mettis Link News

Related News

Supernet sets Aug 17 book closure for right issue entitlement

PSX Closing Bell: A Runaway Rally

Chinese shareholders to sell 18.31% stake in Masood Textile to UAE firm

Name	Price/Vol	%Chg/NChg
KSE100	180,014.93 294.91M	1.66% 2931.71
ALLSHR	108,372.13 738.00M	1.30% 1386.88
KSE30	53,821.81 143.92M	1.87% 985.50
KMI30	253,547.39 118.57M	1.66% 4144.78
KMIALLSHR	69,491.95 365.01M	1.26% 862.49
BKTi	51,843.62 70.63M	2.49% 1258.04
OGTi	34,802.66 8.81M	1.04% 358.83

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	64,760.00	65,030.00 64,680.00	-320.00 -0.49%
BRENT CRUDE	80.03	80.35 79.04	0.58 0.73%
RICHARDS BAY COAL MONTHLY	107.75	0.00 0.00	1.75 1.65%
ROTTERDAM COAL MONTHLY	116.50	116.50 116.50	-1.40 -1.19%
USD RBD PALM OLEIN	1,175.00	1,175.00 1,175.00	0.00 0.00%
CRUDE OIL - WTI	75.76	76.04 74.64	0.54 0.72%
SUGAR #11 WORLD	15.17	15.28 15.06	0.13 0.86%